• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 25-NSE filed by Silver Spike Acquisition Corp II

    3/24/23 4:10:50 PM ET
    $SPKB
    Blank Checks
    Finance
    Get the next $SPKB alert in real time by email
    NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
    UNITED STATES
    OMB APPROVAL
    OMB Number: 3235-0080
    Expires: March 31, 2018
    Estimated average burden
    hours per response: 1.7
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM 25
    NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
    UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
    Commission File Number 333-252803
    Issuer: Silver Spike Acquisition Corp II
    Exchange: Nasdaq Stock Market LLC
    (Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
    Address: 660 Madison Avenue, Suite 1600
    New York NEW YORK 10065
    Telephone number: (212) 905-4938
    (Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)
    Class A Ordinary Shares, Warrant, and Unit
    (Description of class of securities)
    Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
    17 CFR 240.12d2-2(a)(1)
    17 CFR 240.12d2-2(a)(2)
    17 CFR 240.12d2-2(a)(3)
    17 CFR 240.12d2-2(a)(4)
    Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. 1
    Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
    Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.
    2023-03-24 By Tara Petta AVP
    Date Name Title
    1 Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $SPKB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SPKB

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SPKB
    SEC Filings

    View All

    SEC Form 15-12G filed by Silver Spike Acquisition Corp II

    15-12G - Silver Spike Acquisition Corp II (0001826435) (Filer)

    4/3/23 5:10:39 PM ET
    $SPKB
    Blank Checks
    Finance

    SEC Form 25-NSE filed by Silver Spike Acquisition Corp II

    25-NSE - Silver Spike Acquisition Corp II (0001826435) (Subject)

    3/24/23 4:10:50 PM ET
    $SPKB
    Blank Checks
    Finance

    Silver Spike Acquisition Corp II filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Silver Spike Acquisition Corp II (0001826435) (Filer)

    3/13/23 9:30:46 PM ET
    $SPKB
    Blank Checks
    Finance

    $SPKB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Silver Spike Acquisition Corp II Announces Redemption of Class A Ordinary Shares

    NEW YORK, March 13, 2023 (GLOBE NEWSWIRE) -- Silver Spike Acquisition Corp II (the "Company") today announced that it will redeem all of its outstanding Class A ordinary shares (the "Class A Ordinary Shares"), effective as of March 27, 2023, because the Company will not consummate an initial business combination within the time period required by its amended and restated memorandum and articles of association (the "Articles"). As stated in the Company's Articles, if the Company does not consummate an initial business combination within 24 months of the closing of the Company's initial public offering, or March 15, 2023, the Company will: (i) cease all operations except for the purpose of

    3/13/23 9:23:35 PM ET
    $SPKB
    Blank Checks
    Finance

    Eleusis and Silver Spike Acquisition Corp. II Mutually Agree to Terminate Business Combination Agreement

    Eleusis, a clinical-stage life science company that aims to unlock the therapeutic potential of psychedelics, and Silver Spike Acquisition Corp. II ("Silver Spike II" or "SPKB") (NASDAQ:SPKB), a publicly traded special purpose acquisition company ("SPAC"), today announced that they have mutually agreed to terminate their previously announced agreement and plan of merger (the "Business Combination Agreement"), effective immediately, as a result of current unfavorable market conditions. Silver Spike II intends to continue in its efforts to identify a prospective target business for an initial business combination. Additional information about the termination of the Business Combination Agre

    6/9/22 4:05:00 PM ET
    $SPKB
    Blank Checks
    Finance

    Eleusis Announces Notice of Allowance for US Patent Application with Claims Covering Lead Drug Candidate ELE-Psilo

    Eleusis Holdings Ltd announced today it has received a Notice of Allowance for its proprietary psilocin salt form and accompanying formulations from the US Patent and Trademark Office. This salt form and formulations are being developed as Eleusis' lead drug candidate, ELE-Psilo. ELE-Psilo is an investigational psychedelic drug candidate designed to deliver psilocybin's active moiety, psilocin, by intravenous administration. Psilocybin is a prodrug found naturally in certain species of fungi that is metabolized into its pharmacologically active form, psilocin. Eleusis is developing its proprietary salt form of psilocin to enable practical delivery of psilocin directly, and in the case of E

    3/29/22 8:00:00 AM ET
    $SPKB
    Blank Checks
    Finance

    $SPKB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Silver Spike Acquisition Corp II

    SC 13G - Silver Spike Acquisition Corp II (0001826435) (Subject)

    2/14/23 1:58:15 PM ET
    $SPKB
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Silver Spike Acquisition Corp II (Amendment)

    SC 13G/A - Silver Spike Acquisition Corp II (0001826435) (Subject)

    2/14/23 8:26:46 AM ET
    $SPKB
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Silver Spike Acquisition Corp II (Amendment)

    SC 13G/A - Silver Spike Acquisition Corp II (0001826435) (Subject)

    2/14/23 6:06:05 AM ET
    $SPKB
    Blank Checks
    Finance